Significant correlation between ratio of brachial pre-ejection period to ejection time and left ventricular ejection fraction and mass index in patients with chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 6, 2011, Pages 1895-1902

  Chen, Szu Chia ^a,b   Chang, Jer Ming ^a,b,c   Liu, Wan Chun ^a,b   Tsai, Jer Chia ^a,c   Chen, Ling I ^a   Lin, Ming Yen ^a   Hsu, Po Chao ^a   Lin, Tsung Hsien ^a,c   Su, Ho Ming ^a,b,c   Hwang, Shang Jyh ^a,c   Chen, Hung Chun ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

brachial ejection time; brachial pre ejection period; chronic kidney disease; left ventricular ejection fraction; left ventricular mass index

Indexed keywords

ALBUMIN; CALCIUM; CHOLESTEROL; GLUCOSE; PHOSPHATE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION TIME; HEART LEFT VENTRICLE MASS; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ANKLE BRACHIAL INDEX; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79958156643     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq639     Document Type: Article

References (46)

1. US Renal Data System. USRDS 2005 Annual Data Report. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD, 2005.
2. Hsu CC, Hwang SJ, Wen CP et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis 2006; 48: 727-738.
3. Johnson CA, Levey AS, Coresh J et al. Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician 2004; 70: 869-876. (Pubitemid 39201438)
4. Paoletti E, Bellino D, Cassottana P et al. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis 2005; 46: 320-327. (Pubitemid 41040362)
5. Stewart GA, Gansevoort RT, Mark PB et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int 2005; 67: 217-226. (Pubitemid 40019243)
6. Silberberg JS, Barre PE, Prichard SS et al. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286-290. (Pubitemid 19202488)
7. Cintron G, Johnson G, Francis G et al. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. 1993 87: VI17-VI23. (Pubitemid 23164218)
8. Garrard CL Jr, Weissler AM, Dodge HT. The relationship of alterations in systolic time intervals to ejection fraction in patients with cardiac disease. Circulation 1970; 42: 455-462.
9. Lewis RP, Rittogers SE, Froester WF et al. A critical review of the systolic time intervals. Circulation 1977; 56: 146-158. (Pubitemid 8247470)
10. Veyrat C, Larrazet F, Pellerin D. Renewed interest in preejectional isovolumic phase: new applications of tissue Doppler indexes: implications to ventricular dyssynchrony. Am J Cardiol 2005; 96: 1022-1030. (Pubitemid 41362532)
11. Yamashina A, Tomiyama H, Takeda K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364. (Pubitemid 34752554)
12. Chen SC, Chang JM, Tsai JC et al. A new systolic parameter defined as the ratio of brachial pre-ejection period to brachial ejection time predicts overall and cardiovascular mortality in hemodialysis patients. Hypertens Res 2010; 33: 492-498.
13. Su HM, Lin TH, Lee CS et al. Myocardial performance index derived from brachial-ankle pulse wave velocity: a novel and feasible parameter in evaluation of cardiac performance. Am J Hypertens 2009; 22: 871-876.
14. Chen SC, Chang JM, Tsai JC et al. A systolic parameter defined as the ratio of brachial pre-ejection period to brachial ejection time predicts cardiovascular events in patients with chronic kidney disease. Circ J 2010; 74: 2206-2210.
15. Boutouyrie P, Tropeano AI, Asmar R et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10-15. (Pubitemid 34098081)
16. Lehmann ED. Clinical value of aortic pulse-wave velocity measurement. Lancet 1999; 354: 528-529. (Pubitemid 29381361)
17. Wang MC, Tsai WC, Chen JY et al. Arterial stiffness correlated with cardiac remodelling in patients with chronic kidney disease. Nephrology (Carlton) 2007; 12: 591-597.
18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
19. Tomiyama H, Yamashina A, Arai T et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement-a survey of 12517 subjects. Atherosclerosis 2003; 166: 303-309. (Pubitemid 36071689)
20. Yokoyama H, Shoji T, Kimoto E et al. Pulse wave velocity in lowerlimb arteries among diabetic patients with peripheral arterial disease. J Atheroscler Thromb 2003; 10: 253-258.
21. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
22. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458. (Pubitemid 16119719)
23. McKee PA, Castelli WP, McNamara PM et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-1446.
24. Messerli FH. Clinical determinants and consequences of left ventricular hypertrophy. Am J Med 1983; 75: 51-56. (Pubitemid 13009934)
25. Boudoulas H, Mantzouratos D, Sohn YH et al. Left ventricular mass and systolic performance in chronic systemic hypertension. Am J Cardiol 1986; 57: 232-237. (Pubitemid 16140391)
26. Weber T, Auer J, Lamm G et al. Arterial stiffness, central blood pressures, and wave reflections in cardiomyopathy-implications for risk stratification. J Card Fail 2007; 13: 353-359. (Pubitemid 46977794)
27. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942. (Pubitemid 34258697)
28. Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439. (Pubitemid 29218240)
29. Tanaka H, Munakata M, Kawano Y et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 2009; 27: 2022-2027.
30. Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart 2004; 90: 464-470. (Pubitemid 38406929)
31. Park CW, Shin YS, Kim CM et al. Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis 2002; 40: 1230-1239. (Pubitemid 35403135)
32. Levin NW, Handelman GJ, Coresh J et al. Reverse epidemiology: a confusing, confounding, and inaccurate term. Semin Dial 2007; 20: 586-592.
33. Takeda A, Toda T, Iwamoto H et al. Long-term evolution and changing associations of left ventricular hypertrophy after starting hemodialysis. Nephron Clin Pract 2008; 110: c126-c132.
34. Horwich TB, Kalantar-Zadeh K, MacLellan RWet al. Albumin levels predict survival in patients with systolic heart failure. Am Heart J 2008; 155: 883-889.
35. London GM. Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 2002; 17: 29-36. (Pubitemid 34157116)
36. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 2001; 12: 1079-1084. (Pubitemid 32378350)
37. Rider OJ, Petersen SE, Francis JM et al. Ventricular hypertrophy and cavity dilatation in relation to body mass index in females with uncomplicated obesity. Heart 2010 [Epub ahead of print].
38. Rider OJ, Francis JM, Ali MK et al. Determinants of left ventricular mass in obesity; a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2009; 11: 9.
39. Ross J Jr. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. Circulation 1991; 83: 1076-1083.
40. Lewis SJ, Sawada SG, Ryan Tet al. Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium. Am Heart J 1991; 121: 1088-1094.
41. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
42. Jenkins GH, Grieve LA, Yacoub MH et al. Effect of simvastatin on ejection fraction in cardiac transplant recipients. Am J Cardiol 1996; 78: 1453-1456. (Pubitemid 126657249)
43. Ono K, Tsuchida A, Kawai H et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 2003; 14: 1591-1598. (Pubitemid 36687061)
44. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Diabetes Association and the American Heart Association September 18-20, 1992 New Orleans, Louisiana. Circulation 1993; 88: 819-828.
45. Leskinen Y, Salenius JP, Lehtimaki T et al. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis 2002; 40: 472-479. (Pubitemid 34971274)
46. Ronco C, Haapio M, House AA et al. Cardiorenal syndrome. J Am Coll Cardiol 2008; 52: 1527-1539